These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1660606)
1. Effects of single and repeated electroconvulsive therapy sessions on plasma ACTH, prolactin, growth hormone and cortisol concentrations. Kronfol Z; Hamdan-Allen G; Goel K; Hill EM Psychoneuroendocrinology; 1991; 16(4):345-52. PubMed ID: 1660606 [TBL] [Abstract][Full Text] [Related]
2. Hormone response to repeated electroconvulsive therapy: effects of naloxone. Haskett RF; Zis AP; Albala AA Biol Psychiatry; 1985 Jun; 20(6):623-33. PubMed ID: 2986737 [TBL] [Abstract][Full Text] [Related]
3. Selective effects of ECT on hypothalamic-pituitary activity. Whalley LJ; Eagles JM; Bowler GM; Bennie JG; Dick HR; McGuire RJ; Fink G Psychol Med; 1987 May; 17(2):319-28. PubMed ID: 3037582 [TBL] [Abstract][Full Text] [Related]
4. Gender but not stimulus parameters influence prolactin response to electroconvulsive therapy. Motreja S; Subbakrishna DK; Subhash MN; Gangadhar BN; Janakiramaiah N; Parameshwara G Psychoneuroendocrinology; 1997 Jul; 22(5):337-48. PubMed ID: 9279939 [TBL] [Abstract][Full Text] [Related]
5. The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients. Weizman A; Gil-Ad I; Grupper D; Tyano S; Laron Z Psychopharmacology (Berl); 1987; 93(1):122-6. PubMed ID: 2957720 [TBL] [Abstract][Full Text] [Related]
6. Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness. Apéria B; Bergman H; Engelbrektson K; Thorén M; Wetterberg L Acta Psychiatr Scand; 1985 Dec; 72(6):536-41. PubMed ID: 3002132 [TBL] [Abstract][Full Text] [Related]
7. Hormone pattern and post-treatment attitudes in patients with major depressive disorder given electroconvulsive therapy. Apéria B Acta Psychiatr Scand; 1986 Mar; 73(3):271-4. PubMed ID: 3012951 [TBL] [Abstract][Full Text] [Related]
8. Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness. Apéria B; Thorén M; Zettergren M; Wetterberg L Acta Psychiatr Scand; 1984 Oct; 70(4):361-9. PubMed ID: 6093435 [TBL] [Abstract][Full Text] [Related]
9. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. Linkowski P; Mendlewicz J; Kerkhofs M; Leclercq R; Golstein J; Brasseur M; Copinschi G; Van Cauter E J Clin Endocrinol Metab; 1987 Jul; 65(1):141-52. PubMed ID: 3034952 [TBL] [Abstract][Full Text] [Related]
10. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report]. Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757 [TBL] [Abstract][Full Text] [Related]
11. Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time. Papakostas Y; Markianos M; Pehlivanidis A; Papadimitriou GN; Zervas IM; Daras M; Stefanis C Biol Psychiatry; 1996 Mar; 39(6):444-7. PubMed ID: 8679790 [TBL] [Abstract][Full Text] [Related]
12. Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy. Florkowski CM; Crozier IG; Nightingale S; Evans MJ; Ellis MJ; Joyce P; Donald RA Clin Endocrinol (Oxf); 1996 Feb; 44(2):163-8. PubMed ID: 8849570 [TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive therapy and plasma prostaglandin E2 metabolite in major depressive disorder. Mathe AA; Bergman P; Aperia B; Wetterberg L Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):701-7. PubMed ID: 2830639 [TBL] [Abstract][Full Text] [Related]
14. Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome. Deakin JF; Ferrier IN; Crow TJ; Johnstone EC; Lawler P Br J Psychiatry; 1983 Dec; 143():618-24. PubMed ID: 6661605 [TBL] [Abstract][Full Text] [Related]
15. Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients. Christie JE; Whalley LJ; Brown NS; Dick H Br J Psychiatry; 1982 Mar; 140():268-73. PubMed ID: 6807386 [TBL] [Abstract][Full Text] [Related]
16. Effect of the anesthetic agent propofol on hormonal responses to ECT. Mitchell P; Smythe G; Torda T Biol Psychiatry; 1990 Aug; 28(4):315-24. PubMed ID: 2168761 [TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Balldin J; Granérus AK; Lindstedt G; Modigh K; Wålinder J Psychopharmacology (Berl); 1982; 76(4):371-6. PubMed ID: 6812112 [TBL] [Abstract][Full Text] [Related]
18. Effect of stimulus intensity on prolactin and cortisol release induced by unilateral electroconvulsive therapy. Zis AP; Yatham LN; Lam RW; Clark CM; Srisurapanont M; McGarvey K Neuropsychopharmacology; 1996 Sep; 15(3):263-70. PubMed ID: 8873109 [TBL] [Abstract][Full Text] [Related]
19. Effects of ECT course on TSH and prolactin responses to TRH in depressed patients. Lykouras L; Markianos M; Hatzimanolis J; Stefanis C J Affect Disord; 1991 Dec; 23(4):191-7. PubMed ID: 1791264 [TBL] [Abstract][Full Text] [Related]
20. Prolactin and thyrotropin in serum during electroconvulsive therapy in patients with major depressive illness. Apéria B; Thorén M; Wetterberg L Acta Psychiatr Scand; 1985 Sep; 72(3):302-8. PubMed ID: 4072731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]